Project IV: Gender, Sex Hormones and Stress-related Smoking (Saladin &Gray) Even with the use of evidence-based treatments, most smokers are unsuccessful when attempting to quit, and cessation rates are particulariy discouraging among women. Gender and sex hormone influences on the relationships between stress, craving, and smoking behavior may be key factors underiying this important health disparity. Recent laboratory findings support this assertion, but further work is needed to (a) measure and characterize the relationship between gender/sex hormones and craving experienced by female and male smokers in their "real worid" (i.e., non-laboratory) environment, (b) examine the relationship between gender/sex hormones and stress-induced changes in smoking behavior, and (c) examine the treatment potential of a novel pharmacological agent (oxytocin) that may address gender-relevant stress-responsive smoking behaviors. A mixed naturalistic and laboratory research strategy is proposed to address current gaps in knowledge. Over a two-week period, female and male smokers will provide daily saliva samples for measurement of sex hormones, and will ufilize a newly developed and validated software implemented on a personal digital assistant (iPhone) to provide real-fime responses to smoking-related and neutral picture cues presented mulfiple times daily in their day-to-day natural environment. Participants will then take part in a laboratory session that will examine the effects of oxytocin on stress reactivity and smoking behavior. Prior to the session, participants will abstain from smoking for 12 hours and provide a salivary sample for measurement of stress/sex hormones (Cortisol, estradiol, progesterone, testosterone) levels. Next, participants will receive either oxytocin or placebo and then be exposed to the Trier Social Stress Test (TSST). Measures collected at mulfiple fime points during the laboratory session will include: craving, stress, negative emofion, heart rate, blood pressure, skin conductance, and Cortisol. Afterthe TSST, participants will complete a smoking resistance task (SRT) in which they will receive a monetary reward for every 5-min period they resist smoking. After the SRT, participants will be allowed to smoke freely during a 1-hour ad libitum smoking period (ASP), with smoking topography assessed via a portable device. It is expected that, in "real worid" setfings, females will be more reacfive to smoking-related cues than male smokers, and that, among females, the ratio of estradiol to progesterone will be positively related to craving. In the laboratory, it is predicted that (a) females will evidence greater stress, craving, and smoking behavior, but less neuroendocrine (Cortisol) reactivity, to the TSST, and (b) oxytocin vs. placebo, will attenuate stress, craving, and Cortisol response to the TSST. Findings from the proposed study will substantially address a key gender-related health disparity, potenfially informing the development of gender-speciflc intervenfions to enhance female smokers'response to cessation treatments. Therefore, the knowledge to be gained may yield signiflcant public health benefits.

Public Health Relevance

Cigarette smoking is arguably the single greatest preventable cause of morbidity and mortality. Importanfiy, women appear to have more difficulty quitting smoking than men. In an effort to increase understanding of this signiflcant health disparity, the proposed study will employ novel and established research methods to examine the (a) role of sex hormones in craving/stress factors that affect the smoking behavior of women and men, and (b) treatment potenfial of a new medicafion.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
2P50DA016511-11
Application #
8366433
Study Section
Special Emphasis Panel (ZRG1-EMNR-Q (50))
Project Start
Project End
Budget Start
2012-08-15
Budget End
2013-07-31
Support Year
11
Fiscal Year
2012
Total Cost
$243,741
Indirect Cost
$79,772
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Cason, Angie M; Kohtz, Amy; Aston-Jones, Gary (2016) Role of Corticotropin Releasing Factor 1 Signaling in Cocaine Seeking during Early Extinction in Female and Male Rats. PLoS One 11:e0158577
Glover, Elizabeth J; McDougle, Molly J; Siegel, Griffin S et al. (2016) Role for the Rostromedial Tegmental Nucleus in Signaling the Aversive Properties of Alcohol. Alcohol Clin Exp Res 40:1651-61
Allen, Alicia M; McRae-Clark, Aimee L; Carlson, Samantha et al. (2016) Determining menstrual phase in human biobehavioral research: A review with recommendations. Exp Clin Psychopharmacol 24:1-11
Brady, Kathleen T; McCauley, Jenna L; Back, Sudie E (2016) Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update. Am J Psychiatry 173:18-26
Moran-Santa Maria, M M; Baker, N L; McRae-Clark, A L et al. (2016) Effects of yohimbine and drug cues on impulsivity and attention in cocaine-dependent men and women and sex-matched controls. Drug Alcohol Depend 162:56-63
Tomko, Rachel L; Bountress, Kaitlin E; Gray, Kevin M (2016) Personalizing substance use treatment based on pre-treatment impulsivity and sensation seeking: A review. Drug Alcohol Depend 167:1-7
Leong, Kah-Chung; Zhou, Luyi; Ghee, Shannon M et al. (2016) Oxytocin decreases cocaine taking, cocaine seeking, and locomotor activity in female rats. Exp Clin Psychopharmacol 24:55-64
Leong, Kah-Chung; Berini, Carole R; Ghee, Shannon M et al. (2016) Extended cocaine-seeking produces a shift from goal-directed to habitual responding in rats. Physiol Behav 164:330-5
Smith, Philip H; Kasza, Karin A; Hyland, Andrew et al. (2015) Gender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey. Nicotine Tob Res 17:463-72
Weinberger, Andrea H; Smith, Philip H; Allen, Sharon S et al. (2015) Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation. Nicotine Tob Res 17:407-21

Showing the most recent 10 out of 90 publications